1

Weigang Dong , Yan Yin ,Jianwen Qin*.Impact   of chronic obstructive pulmonary disease on the efcacy   and safety of neoadjuvant immune checkpoint inhibitors combined   with chemotherapy for resectable non-small cell lung cancer:   a retrospective cohort study.BMC Cancer (2024) 24:153

3.8

2

     Identification of Recurrent   Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor   Receptor 2 as Potential Drivers in Non-Small-Cell Lung Cancer and Other   Cancer Types . JCO Precis Oncol .2022
   Feb ;6:e2100325. doi :10.1200/PO.21.00325.

5.479

3

     Identification and Validation of a GPX4-Related Immune Prognostic Signature   for Lung Adenocarcinoma . J Oncol .2022 May 17. doi :10.1155/2022/9054983.
  Zhenxing Feng , Yan Yin , Bin Liu , Yafang Zheng , Dongsheng Shi , Hong Zhang   , JianwenQin .

4.501

4

ZNF143 Expression is   Associated with COPD and Tumor Microenvironment in Non-Small Cell Lung Cancer   . Int J Chron Obstruct Pulmon Dis .2022 Apr 2;17:685-700.

2.893

5

       Prognostic and Immunological Role of FAT Family Genes in Non - Small Cell   Lung Cancer . Cancer Control .2022 Jan - Dec ;29:10732748221076682. doi   :10.1177/10732748221076682.

2.339

6

Multi-line treatment   with tyrosine kinase inhibitors enabled in 4-year survival for patient with   stage IV lung adenocarcinoma: a case report . Ann Palliat Med .2020 Oct 27:   apm -20-1514.    

1.925